Literature DB >> 9989338

Cefepime versus ceftriaxone for empiric treatment of hospitalized patients with community-acquired pneumonia.

J Borja, F Jané.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9989338      PMCID： PMC89101     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  4 in total

1.  Cefepime versus ceftriaxone for empiric treatment of hospitalized patients with community-acquired pneumonia. The Cefepime Study Group.

Authors:  M Zervos; M Nelson
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

2.  Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America.

Authors:  J G Bartlett; R F Breiman; L A Mandell; T M File
Journal:  Clin Infect Dis       Date:  1998-04       Impact factor: 9.079

Review 3.  Community-acquired pneumonia.

Authors:  J G Bartlett; L M Mundy
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

4.  Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and the Food and Drug Administration.

Authors:  A W Chow; C B Hall; J O Klein; R B Kammer; R D Meyer; J S Remington
Journal:  Clin Infect Dis       Date:  1992-11       Impact factor: 9.079
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.